Non-Invasive Prenatal Testing Market 2024 Global Manufacturers, Application, Technology Market Resea

Author : Rushi Goswami | Published On : 10 Jul 2024

Non-Invasive Prenatal Testing (NIPT) Market Size

The Non-Invasive Prenatal Testing (NIPT) Market, valued at USD 6.4 billion in 2023, is projected to reach USD 17.75 billion by 2031, growing at a compound annual growth rate (CAGR) of 13.6% over the forecast period from 2024 to 2031. This growth is driven by the increasing demand for safer, non-invasive methods to detect chromosomal abnormalities in fetuses, advancements in genomic technology, and rising awareness among expectant parents. The growing preference for NIPT over traditional invasive procedures, due to its high accuracy and lower risk, along with enhanced support from healthcare providers and insurance companies, further propels market expansion.

Get Your Free Report Sample: 

Key Market Segmentation

By Product

  • Consumables & Reagents
  • Instruments

By Method

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-free DNA in Maternal Plasma Tests

By Pregnancy Risk

  • High & Average Risk
  • Low Risk

By Gestation Period

  • 0-12 Weeks
  • 13-24 Weeks
  • 25-36 Weeks

By Application

  • Trisomy
  • Microdeletion Syndrome
  • Other Applications

By Technology

  • NGS
  • Array Technology
  • PCR
  • Others

By End-User

  • Hospitals & Clinics
  • Diagnostic Laboratories

Key factors driving the market growth include:

  • Increasing Maternal Age and Pregnancy Complications: The rising trend of delayed pregnancies and associated risks, along with the growing incidence of chromosomal abnormalities, is boosting the demand for NIPT as an effective prenatal screening tool.
  • Technological Advancements in Genetic Testing: Continuous advancements in sequencing technologies, bioinformatics, and the expansion of genetic testing capabilities are enhancing the accuracy, reliability, and accessibility of NIPT services worldwide.
  • Rising Awareness and Acceptance: Growing awareness among expecting parents about the benefits of early detection of fetal abnormalities, coupled with increasing acceptance of non-invasive prenatal testing methods, is driving market adoption.

Geographically, North America is expected to dominate the NIPT market, followed closely by Europe, owing to favorable reimbursement policies, high healthcare expenditure, and robust healthcare infrastructure supporting prenatal screening programs. Meanwhile, Asia-Pacific is anticipated to witness rapid growth, driven by increasing healthcare investments and rising awareness about prenatal care.

Leading diagnostic companies and laboratories are focusing on expanding their NIPT product portfolios, improving test accuracy, and enhancing service accessibility to cater to the rising global demand for prenatal genetic screening.

For further insights into the Non-Invasive Prenatal Testing (NIPT) market, please visit SNS Insider.

Other Related Reports

Artificial Tears Market

Patient Portal Market

Eyewear Market

BOTOX Market

About SNS Insider

SNS Insider is a leading provider of market research and analysis, specializing in healthcare diagnostics and genetic testing sectors. We offer comprehensive insights into industry trends, market forecasts, and strategic recommendations to help businesses navigate the competitive landscape.